Stewardship, AMR Technology, and Ethics

Overview

About this study

The purpose of this study is to explore ethical, legal, and social implications (ELSI) of stakeholder attitudes toward new genomic technologies, including the contribution of these new advances to AM stewardship, to understand how stakeholder views and expectations of ethical issues and microbial technologies are shaped by a sense of professionalism and moral responsibility for clinical roles, population health outcomes, and health system policies, and to identify barriers and facilitators as microbial technologies are integrated into treatment decisions that also serve AM stewardship goals.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Lay stakeholders must be a participant enrolled in the RASP study.
Have the ability to converse in English.
Be a legal adult 18 years of age or older.
Must have the capacity to consent to participate in this study.
Expert stakeholders must be an employee of Mayo Clinic Rochester and a staff or faculty member involved in the RASP Study (IRB# 19-012521).
Jave the ability to converse in English.
Be a legal adult 18 years of age or older.
Must have the capacity to consent to participate in this study.

Exclusion Criteria:

Not a participant enrolled in the RASP study or a staff or faculty member of Mayo Clinic involved in the RASP Study (IRB# 19-012521).
Unable to converse in English.
Individuals less than 18 years of age.
Do not have the capacity to consent to participate in this study.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Karen Meagher, Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Karen Meagher Ph.D. (507) 293-9528 Meagher.Karen@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Karen Meagher, Ph.D.

Closed-enrolling by invitation

Contact information:

Karen Meagher Ph.D.

(507) 293-9528

Meagher.Karen@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials